• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

疫苗接种的经济考虑因素系统图:在难以触及的人群中的应用。

A systems map of the economic considerations for vaccination: Application to hard-to-reach populations.

机构信息

Public Health Informatics, Computational, and Operations Research (PHICOR), City University of New York (CUNY) Graduate School of Public Health and Health Policy, New York City, NY, United States.

Global Immunization Division, Centers for Disease Control and Prevention (CDC), Atlanta, GA, United States.

出版信息

Vaccine. 2021 Nov 5;39(46):6796-6804. doi: 10.1016/j.vaccine.2021.05.033. Epub 2021 May 25.

DOI:10.1016/j.vaccine.2021.05.033
PMID:34045101
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8889938/
Abstract

BACKGROUND

Understanding the economics of vaccination is essential to developing immunization strategies that can be employed successfully with limited resources, especially when vaccinating populations that are hard-to-reach.

METHODS

Based on the input from interviews with 24 global experts on immunization economics, we developed a systems map of the mechanisms (i.e., necessary steps or components) involved in vaccination, and associated costs and benefits, focused at the service delivery level. We used this to identify the mechanisms that may be different for hard-to-reach populations.

RESULTS

The systems map shows different mechanisms that determine whether a person may or may not get vaccinated and the potential health and economic impacts of doing so. The map is divided into two parts: 1) the costs of vaccination, representing each of the mechanisms involved in getting vaccinated (n = 23 vaccination mechanisms), their associated direct vaccination costs (n = 18 vaccination costs), and opportunity costs (n = 5 opportunity costs), 2) the impact of vaccination, representing mechanisms after vaccine delivery (n = 13 impact mechanisms), their associated health effects (n = 10 health effects for beneficiary and others), and economic benefits (n = 13 immediate and secondary economic benefits and costs). Mechanisms that, when interrupted or delayed, can result in populations becoming hard-to-reach include getting vaccines and key stakeholders (e.g., beneficiaries/caregivers, vaccinators) to a vaccination site, as well as vaccine administration at the site.

CONCLUSION

Decision-makers can use this systems map to understand where steps in the vaccination process may be interrupted or weak and identify where gaps exist in the understanding of the economics of vaccination. With improved understanding of system-wide effects, this map can help decision-makers inform targeted interventions and policies to increase vaccination coverage in hard-to-reach populations.

摘要

背景

了解疫苗接种的经济学对于制定能够在有限资源下成功实施的免疫策略至关重要,尤其是在为难以接触到的人群接种疫苗时。

方法

根据对 24 名全球免疫经济学专家的访谈内容,我们制定了一个疫苗接种机制系统图,包括与服务提供层面相关的机制(即必要步骤或组成部分)及其相关成本和收益。我们利用这一系统图来确定针对难以接触到的人群的不同机制。

结果

系统图展示了决定一个人是否接种疫苗以及接种疫苗的潜在健康和经济效益的不同机制。该图分为两部分:1)疫苗接种成本,代表了接种疫苗所涉及的各个机制(共 23 个疫苗接种机制)、其相关的直接疫苗接种成本(共 18 个疫苗接种成本)和机会成本(共 5 个机会成本);2)疫苗接种的影响,代表疫苗接种后发生的机制(共 13 个影响机制)、其相关的健康效果(共 10 个受益人和其他人的健康效果)和经济效益(共 13 个直接和二次经济效益和成本)。当疫苗接种和关键利益相关者(如受益人/照顾者、接种者)到达接种地点以及在接种点进行疫苗接种等机制受到干扰或延迟时,可能导致人群变得难以接触。

结论

决策者可以使用这个系统图来了解疫苗接种过程中的哪些步骤可能会中断或薄弱,并确定在疫苗接种经济学理解方面存在哪些差距。通过对系统整体效果的更好理解,该图可以帮助决策者为难以接触到的人群提供有针对性的干预措施和政策,以提高疫苗接种覆盖率。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f72b/8889938/2397d6c56fb2/nihms-1704468-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f72b/8889938/2397d6c56fb2/nihms-1704468-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f72b/8889938/2397d6c56fb2/nihms-1704468-f0001.jpg

相似文献

1
A systems map of the economic considerations for vaccination: Application to hard-to-reach populations.疫苗接种的经济考虑因素系统图:在难以触及的人群中的应用。
Vaccine. 2021 Nov 5;39(46):6796-6804. doi: 10.1016/j.vaccine.2021.05.033. Epub 2021 May 25.
2
Systematic review of the costs for vaccinators to reach vaccination sites: Incremental costs of reaching hard-to-reach populations.接种人员到达接种点的成本系统评价:为覆盖难以触及的人群而增加的成本。
Vaccine. 2021 Jul 30;39(33):4598-4610. doi: 10.1016/j.vaccine.2021.05.019. Epub 2021 Jul 6.
3
Promoting, seeking, and reaching vaccination services: A systematic review of costs to immunization programs, beneficiaries, and caregivers.促进、寻求和实现疫苗接种服务:免疫规划、受益人和照护者成本的系统评价。
Vaccine. 2021 Jul 22;39(32):4437-4449. doi: 10.1016/j.vaccine.2021.05.075. Epub 2021 Jul 1.
4
Budget-Impact Analysis of Alternative Herpes Zoster Vaccine Strategies: A U.S. HMO Perspective.替代带状疱疹疫苗策略的预算影响分析:美国 HMO 视角。
J Manag Care Spec Pharm. 2016 Jul;22(7):872-88. doi: 10.18553/jmcp.2016.22.7.872.
5
Door - to - door immunization strategy for improving access and utilization of immunization Services in Hard-to-Reach Areas: a case of Migori County, Kenya.门到门免疫策略在难以到达地区改善免疫服务的可及性和利用度:肯尼亚米戈里县案例。
BMC Public Health. 2019 Aug 7;19(1):1064. doi: 10.1186/s12889-019-7415-8.
6
Defining hard-to-reach populations for vaccination.定义疫苗接种的难以触及人群。
Vaccine. 2019 Sep 3;37(37):5525-5534. doi: 10.1016/j.vaccine.2019.06.081. Epub 2019 Aug 7.
7
Economic value of vaccinating geographically hard-to-reach populations with measles vaccine: A modeling application in Kenya.为地理上难以到达的人群接种麻疹疫苗的经济价值:肯尼亚的建模应用。
Vaccine. 2019 Apr 17;37(17):2377-2386. doi: 10.1016/j.vaccine.2019.03.007. Epub 2019 Mar 25.
8
Economic Benefits of Immunization for 10 Pathogens in 94 Low- and Middle-Income Countries From 2011 to 2030 Using Cost-of-Illness and Value-of-Statistical-Life Approaches.2011 年至 2030 年,94 个中低收入国家使用疾病成本和统计生命价值方法计算的 10 种病原体免疫接种的经济效益。
Value Health. 2021 Jan;24(1):78-85. doi: 10.1016/j.jval.2020.07.009. Epub 2020 Oct 17.
9
A case study using the United Republic of Tanzania: costing nationwide HPV vaccine delivery using the WHO Cervical Cancer Prevention and Control Costing Tool.使用坦桑尼亚联合共和国进行案例研究:利用世卫组织宫颈癌预防和控制成本核算工具核算全国范围内 HPV 疫苗接种成本。
BMC Med. 2012 Nov 13;10:136. doi: 10.1186/1741-7015-10-136.
10
Measles, mumps, rubella prevention: how can we do better?麻疹、腮腺炎、风疹预防:我们如何做得更好?
Expert Rev Vaccines. 2021 Jul;20(7):811-826. doi: 10.1080/14760584.2021.1927722. Epub 2021 Jun 7.

引用本文的文献

1
A Systems Map of the Challenges of Climate Communication.气候沟通挑战的系统图谱。
J Health Commun. 2024 Jun 3;29(sup1):77-88. doi: 10.1080/10810730.2024.2361842. Epub 2024 Jun 6.
2
The Need for Systems Approaches for Precision Communications in Public Health.需要采用系统方法进行精准公共卫生传播。
J Health Commun. 2023 Apr 7;28(sup1):13-24. doi: 10.1080/10810730.2023.2220668.
3
Vaccine distribution with drones for less developed countries: A case study in Vanuatu.利用无人机向欠发达国家分发疫苗:瓦努阿图的案例研究。

本文引用的文献

1
Systematic review of the costs and effectiveness of interventions to increase infant vaccination coverage in low- and middle-income countries.系统评价在中低收入国家提高婴儿疫苗接种覆盖率的干预措施的成本和效果。
BMC Health Serv Res. 2019 Oct 22;19(1):741. doi: 10.1186/s12913-019-4468-4.
2
Defining hard-to-reach populations for vaccination.定义疫苗接种的难以触及人群。
Vaccine. 2019 Sep 3;37(37):5525-5534. doi: 10.1016/j.vaccine.2019.06.081. Epub 2019 Aug 7.
3
Spillover effects on health outcomes in low- and middle-income countries: a systematic review.
Vaccine X. 2023 May 15;14:100312. doi: 10.1016/j.jvacx.2023.100312. eCollection 2023 Aug.
4
The role of vaccines in combating antimicrobial resistance (AMR) bacteria.疫苗在对抗抗菌药物耐药性(AMR)细菌方面的作用。
Saudi J Biol Sci. 2021 Dec;28(12):7505-7510. doi: 10.1016/j.sjbs.2021.08.054. Epub 2021 Aug 24.
5
Systematic review of the costs for vaccinators to reach vaccination sites: Incremental costs of reaching hard-to-reach populations.接种人员到达接种点的成本系统评价:为覆盖难以触及的人群而增加的成本。
Vaccine. 2021 Jul 30;39(33):4598-4610. doi: 10.1016/j.vaccine.2021.05.019. Epub 2021 Jul 6.
6
Promoting, seeking, and reaching vaccination services: A systematic review of costs to immunization programs, beneficiaries, and caregivers.促进、寻求和实现疫苗接种服务:免疫规划、受益人和照护者成本的系统评价。
Vaccine. 2021 Jul 22;39(32):4437-4449. doi: 10.1016/j.vaccine.2021.05.075. Epub 2021 Jul 1.
低收入和中等收入国家健康结果的溢出效应:一项系统综述
Int J Epidemiol. 2019 Aug 1;48(4):1387. doi: 10.1093/ije/dyz111.
4
Modeling the economic impact of different vial-opening thresholds for measles-containing vaccines.建立麻疹疫苗不同小瓶开启阈值的经济影响模型。
Vaccine. 2019 Apr 17;37(17):2356-2368. doi: 10.1016/j.vaccine.2019.03.017. Epub 2019 Mar 23.
5
Barriers to effective uptake and provision of immunization in a rural district in Uganda.乌干达农村地区免疫接种有效实施和提供的障碍。
PLoS One. 2019 Feb 14;14(2):e0212270. doi: 10.1371/journal.pone.0212270. eCollection 2019.
6
Malnutrition, morbidity and infection in the informal settlements of Nairobi, Kenya: an epidemiological study.肯尼亚内罗毕非正规住区的营养不良、发病和感染:一项流行病学研究。
Ital J Pediatr. 2019 Jan 14;45(1):12. doi: 10.1186/s13052-019-0607-0.
7
The potential effects of introducing microneedle patch vaccines into routine vaccine supply chains.微针贴片疫苗引入常规疫苗供应链的潜在影响。
Vaccine. 2019 Jan 21;37(4):645-651. doi: 10.1016/j.vaccine.2018.12.008. Epub 2018 Dec 19.
8
The value of tailoring vial sizes to populations and locations.根据人群和地点调整小瓶规格的价值。
Vaccine. 2019 Jan 21;37(4):637-644. doi: 10.1016/j.vaccine.2018.12.010. Epub 2018 Dec 19.
9
Antimicrobial resistance and the role of vaccines.抗菌药物耐药性与疫苗的作用。
Proc Natl Acad Sci U S A. 2018 Dec 18;115(51):12868-12871. doi: 10.1073/pnas.1717157115.
10
Micro-planning for immunization in Kaduna State, Nigeria: Lessons learnt, 2017.尼日利亚卡杜纳州免疫接种微观规划:经验教训,2017 年。
Vaccine. 2018 Nov 19;36(48):7361-7368. doi: 10.1016/j.vaccine.2018.10.020. Epub 2018 Oct 23.